| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 片剂产品(元) | 14,151,618.00 | 43,515,536.00 | 24,562,295.00 | 39,182,493.00 | 18,924,612.00 |
| 注射剂产品(元) | 10,784,441.00 | 23,293,813.00 | 16,589,142.00 | 18,660,533.00 | 7,607,074.00 |
| 原料药(元) | - | 2,410,230.00 | - | 2,938,301.00 | - |
| 其他(元) | 139,752.00 | 4,083,582.00 | 7,929.00 | 8,895,042.00 | 7,298,697.00 |
| 营业成本(元) | |||||
| 片剂产品(元) | 7,135,985.00 | 23,719,627.00 | 12,344,753.00 | 26,918,836.00 | 14,397,894.00 |
| 注射剂产品(元) | 2,304,789.00 | 4,708,478.00 | 2,509,275.00 | 4,620,810.00 | 1,821,378.00 |
| 原料药(元) | - | 1,876,157.00 | - | 2,212,108.00 | - |
| 其他(元) | 37,502.00 | 1,837,960.00 | 3,156.00 | 2,816,465.00 | 197,431.00 |
| 毛利(元) | |||||
| 片剂产品(元) | 7,015,633.00 | 19,795,909.00 | 12,217,542.00 | 12,263,657.00 | 4,526,718.00 |
| 注射剂产品(元) | 8,479,652.00 | 18,585,335.00 | 14,079,867.00 | 14,039,723.00 | 5,785,696.00 |
| 原料药(元) | - | 534,073.00 | - | 726,193.00 | - |
| 其他(元) | 102,250.00 | 2,245,622.00 | 4,773.00 | 6,078,577.00 | 7,101,266.00 |
| 毛利率(%) | |||||
| 片剂产品(%) | 49.57 | 45.49 | 49.74 | 31.30 | 23.92 |
| 注射剂产品(%) | 78.63 | 79.79 | 84.87 | 75.24 | 76.06 |
| 原料药(%) | - | 22.16 | - | 24.71 | - |
| 其他(%) | 73.17 | 54.99 | 60.20 | 68.34 | 97.29 |
| 收入构成(%) | |||||
| 片剂产品(%) | 56.44 | 59.36 | 59.68 | 56.23 | 55.94 |
| 注射剂产品(%) | 43.01 | 31.78 | 40.30 | 26.78 | 22.49 |
| 原料药(%) | - | 3.29 | - | 4.22 | - |
| 其他(%) | 0.56 | 5.57 | 0.02 | 12.77 | 21.57 |
| 毛利构成(%) | |||||
| 片剂产品(%) | 44.98 | 48.09 | 46.45 | 37.04 | 26.00 |
| 注射剂产品(%) | 54.37 | 45.15 | 53.53 | 42.41 | 33.23 |
| 原料药(%) | - | 1.30 | - | 2.19 | - |
| 其他(%) | 0.66 | 5.46 | 0.02 | 18.36 | 40.78 |